Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool April 20, 2005 Stephen D. Simpson	St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well.
The Motley Fool July 20, 2005 Stephen D. Simpson	Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that.
The Motley Fool August 18, 2005 Stephen D. Simpson	Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay.
The Motley Fool August 4, 2006 Stephen D. Simpson	Medtronic's Shock to the System Its guidance cuts rattled the med-tech industry, but long-term trends remain positive. While the going may be tougher now in the ICD space, it's still an attractive long-term opportunity, and investors may want to start looking around for bargains.
The Motley Fool February 17, 2005 Stephen D. Simpson	Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock?
The Motley Fool April 5, 2006 Stephen D. Simpson	St. Jude's Racing Heartbeat Slows Even though the stock got far too expensive, this is still a good company and could still be a viable target for certain large health-care companies that may be in an acquisition frame of mind.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it.
The Motley Fool January 26, 2005 Stephen D. Simpson	St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains.
The Motley Fool April 19, 2006 Stephen D. Simpson	St. Jude Lives and Learns Though dynamics in the ICD market caught it by surprise, this is still a quality med-tech company. Investors, take note.
The Motley Fool October 19, 2007 Billy Fisher	Keeping Pace at St. Jude Medical device maker St. Jude Medical has a strong quarter, but investors weren't impressed.
The Motley Fool May 26, 2005 Stephen D. Simpson	A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges?
The Motley Fool February 23, 2006 Stephen D. Simpson	A Nasty Jolt to Greatbatch Disappointing margins take a bite out of the company's market cap. While valuation here is a bit difficult, any way you slice it, the stock doesn't look too interesting.
The Motley Fool November 18, 2004 W.D. Crotty	Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy.
The Motley Fool February 22, 2006 Stephen D. Simpson	Medtronic's Minor Miss Sluggish sales in several market categories might spook investors.
The Motley Fool July 20, 2006 Stephen D. Simpson	Intersil Still on the Attack New product introductions and market-share gains continue to help results at this analog-chip company. Investors, take note.
The Motley Fool July 18, 2008 Brian Orelli	St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down.
The Motley Fool April 19, 2007 Billy Fisher	A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter.
The Motley Fool July 19, 2006 Stephen D. Simpson	Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too.
The Motley Fool January 25, 2006 Stephen D. Simpson	Is St. Jude Next to Be Wooed? Can St. Jude build upon the jump-start opportunity from Guidant's troubles, or will further market share growth prove to be increasingly hard to come by? Investors, take note.
The Motley Fool January 19, 2006 Stephen D. Simpson	Linear Thinking Linear has carved out a very profitable niche in the high-performance analog chip market. Prospective investors need to be wary of competition, but this is definitely worth a look.
The Motley Fool January 9, 2007 Billy Fisher	St. Jude's Juiced-Up Q4 The medical-device maker shows stronger vital signs. Investors, take note.
The Motley Fool October 17, 2005 Stephen D. Simpson	Is Fairchild a Fair Bet? Internal company trends are improving at the specialist in power semiconductors, but can that continue as the end-markets for its commodity products look shaky? Investors, take note.
The Motley Fool February 17, 2009 Brian Orelli	Investors Heart Medtronic The leaner company is more lovable.
The Motley Fool August 23, 2006 Stephen D. Simpson	Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution.
The Motley Fool January 19, 2012 Seth Jayson	Fairchild Semiconductor International Beats Up on Analysts Yet Again Fairchild Semiconductor International reported earnings on Jan. 19. Here are the numbers you need to know.
The Motley Fool October 13, 2010 Anders Bylund	Make No Mistake: This Is a Great Company on Sale! Linear Technology is getting punished for doing everything right. Take advantage while the injustice lasts.
BusinessWeek January 8, 2007 Mara Der Hovanesian	What's Powering Linear Technology Linear has the highest profit margins in the semiconductor industry, and the company will soon be first on the market with a new series of signal-processing chips for high-growth markets
The Motley Fool April 23, 2011	St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.
The Motley Fool May 24, 2006 S.J. Caplan	Goodbye, Guidant Publicity woes drive Boston Scientific to ditch the Guidant name. In the meantime, Boston Scientific wants to capitalize on its entry into the ICD market, an area experiencing double-digit sales growth. Investors, take note.
The Motley Fool November 9, 2005 Stephen D. Simpson	Greatbatch Keeps Growth Pumping Demand for implantable medical electronics keeps this battery and component maker humming. Investors new to this stock and/or medical technology in general will need to exercise some patience.
The Motley Fool June 11, 2010 Rex Moore	2 Chip Stocks Worth a Look The sector is looking semi-tough again.
The Motley Fool October 22, 2011 Harsh Chauhan	This Stock May Be a Surprisingly Good Buy Medtronic's moves could reap dividends in the future.
The Motley Fool October 28, 2005 Dan Bloom	Flextronics Hit Across the Board Investors paid dearly for the semiconductor contract manufacturer's disappointing quarter.
The Motley Fool January 18, 2012 Evan Niu	Fairchild Semiconductor Shares Jumped: What You Need to Know Shares of Fairchild Semiconductor are jumping today, up by as much as 13%, after peer Linear Technology reported strong guidance, leading the sector higher.
The Motley Fool May 24, 2006 Stephen D. Simpson	Measuring Up Medtronic Everyone loves the med-tech firm. That makes it a dangerous investment.
The Motley Fool July 11, 2011	Fairchild Semiconductor International Earnings Preview Will Fairchild Semiconductor International top analyst expectations for the fifth consecutive quarter on Thursday, July 14?
The Motley Fool July 25, 2011 Jason Moser	Rising Star Buy: St. Jude Medical It's a good time to jump in on this medical-device maker.
The Motley Fool February 12, 2004 Jeff Hwang	Rockin' Medtronic The world's premier medical device maker keeps on growing.
The Motley Fool January 19, 2006 W.D. Crotty	Fair Weather at Fairchild Semi The semiconductor company's improved earnings and sequential sales send the stock soaring
The Motley Fool October 19, 2009 Rob Plaza	Is Fairchild's Rally Over? Predictably, Fairchild Semiconductor's third-quarter results came in ahead of analyst estimates. Like other semiconductor companies, it benefited from improving customer demand and inventory restocking. But is the rally over?
The Motley Fool June 20, 2005 Stephen D. Simpson	Ouch! Guidant Zaps Itself Problems with ICDs have led to a voluntary recall and could fuel a class action suit. While Guidant is doing the right thing now, investors, patients, and doctors may well ask whether more should have been done sooner.
The Motley Fool August 22, 2011 Rex Moore	Let's See If Fairchild Semiconductor's Growth Is for Real Fairchild Semiconductor International carries $244.2 million of goodwill and other intangibles on its balance sheet.
The Motley Fool December 28, 2005	Foolish Fundamentals: GAAP Understanding how companies make adjustments to GAAP earnings will help investors round out their tool kit.
IEEE Spectrum October 2007 Samuel K. Moore	Fairchild Turns 50 This month Fairchild Semiconductor celebrates 50 years in the business.
The Motley Fool January 6, 2005 Stephen D. Simpson	Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past.
The Motley Fool December 11, 2006 Will Frankenhoff	Taiwan Semiconductor: Making Profits Chip by Chip Taiwan Semiconductor should benefit from its leadership position in the semiconductor foundry sector and its attractive valuation versus its peers. The company also pays a dividend of roughly 3%. Investors, take note.
The Motley Fool June 9, 2006 Stephen D. Simpson	National Semiconductor: A Second Bite at the Cherry A tech slide gives folks another shot at an improving semiconductor story. Investors, take note.
The Motley Fool November 3, 2005 Stephen D. Simpson	The At-Odds Couple Johnson & Johnson seems to want out, but Guidant looks willing to grab the shotgun to see that this union is completed. Investors, should the deal fall through, look for J&J to continue shopping and don't be surprised if Guidant attracts attention from Abbott Labs or Boston Scientific.
The Motley Fool February 8, 2006 Tim Beyers	Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's buying now? Dominion Resources... Goodrich Petroleum... iPass... ITT Educational Services... St. Jude Medical...
The Motley Fool October 4, 2004 Selena Maranjian	When Medicare Boosts Stocks More defibrillators in use means higher earnings for some investors.